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doi:10.1016/j.jtcvs.2004.01.009TObjective: The purpose of this study was to determine, on the basis of the late fate
of the intact aortic arch with abnormal tissue after aortic root replacement, whether
the intact aortic arch should be replaced prophylactically at the time of aortic root
replacement for annuloaortic ectasia in Marfan syndrome.
Methods: A retrospective review was performed in 85 patients with Marfan syn-
drome who underwent aortic root replacement for annuloaortic ectasia with or
without aortic dissection (mean age 37 years, range 19-61 years). These 85 patients
were divided into four groups according to the postoperative condition of the
residual aorta. In group I (n  47), the patients underwent aortic root replacement
for annuloaortic ectasia with or without localized dissection in the ascending aorta.
In these patients the residual aorta, including the aortic arch, was therefore intact. In
group II (n  10), the aortic arch was intact, although the descending thoracic aorta
was dissected because of the preoperative type B dissection. In groups III and IV,
the patients had type A dissection involving the transverse arch associated with
annuloaortic ectasia. In group III (n  13), residual dissection existed in the
descending thoracic aorta after concomitant total arch replacement. In group IV
(n  15), the aortic arch and the descending thoracic aorta were dissected.
Results: There were 5 early deaths (3 in group I, 1 in group II, and 1 in group III).
Subsequent operations were required in 10, 5, 6, and 7 cases in groups I, II, III, and
IV, respectively. Regarding the aortic arch, only 2 of 53 survivors of the initial
hospitalization with an intact aortic arch (groups I and II) underwent subsequent
total arch replacement for the onset of dissection in the aortic arch, and 4 of 14
survivors of the initial hospitalization with a residual dissecting arch (group III)
needed subsequent total arch replacement. Actuarial freedom from arch repair
among patients with an intact aortic arch (91% at 15 years) was significantly higher
than that among patients with a residual dissecting arch (49% at 15 years, P 
.0078).
Conclusions: The incidence of new dissection in the residual intact arch after aortic
root replacement was extremely low. Therefore prophylactic replacement of the
intact arch does not appear to be necessary at aortic root replacement for annu-
loaortic ectasia in Marfan syndrome.
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CDSince Dr Antonine Marfan first described acase of Marfan syndrome in 1896,1 there havebeen reports of numerous investigations onthis inheritable disorder of connective tissue,which often evolves to cause progressive di-latation of the aortic root and ascending aor-
ta.2 Recent advances in molecular biology and genetics have
enabled us to elucidate the precise mechanism of this ab-
normal arterial elasticity,3,4 and it is now known that Marfan
syndrome is associated with mutations in the fibrillin 1 gene
on chromosome 15q21.1. Fibrillin is an important compo-
nent of connective tissue microfibrils, which form a mesh-
work of elastin in the aorta. Depletion of fibrillin may alter
the pattern of elastin deposition so that the aorta is less able
to withstand recurrent wall stress, resulting in progressive
aortic dilatation, dissection, or rupture. Prophylactic surgery
thus is crucial to improvement of the overall prognosis for
patients with Marfan syndrome. The current recommenda-
tion is to operate when the size of the aortic root or ascend-
ing aorta is 5.0 to 5.5 cm. In patients with additional risk
factors, such as progressive dilatation of an aneurysm or a
family history of dissection, rupture, or aortic regurgitation,
surgery for annuloaortic ectasia should be considered for a
smaller size of the aortic root.5-8 However, the patient with
Marfan syndrome still has the potential risk of dissection or
rupture in the residual intact aorta after aortic root replace-
ment for isolated annuloaortic ectasia. Therefore emergency
total arch replacement through median resternotomy will be
required if acute dissection occurs in the residual aortic arch
after aortic root replacement. It is generally accepted that
elective concomitant total arch replacement for an intact
arch has a lower risk than does emergency total arch re-
placement through median resternotomy.
The purpose of this study was to determine whether not
the intact aortic arch should be replaced prophylactically
and aggressively at the time of aortic root replacement for
annuloaortic ectasia in Marfan syndrome. To accomplish
this, we studied the late fate of the intact residual arch after
aortic root replacement in a series of 85 patients.
Patients and Methods
Between October 1979 and May 2002, a total of 117 patients with
Marfan syndrome underwent surgery for cardiovascular disease at
the National Cardiovascular Center, Osaka, Japan. The diagnosis
of Marfan syndrome was based on internationally established
diagnostic criteria.9 Among the 117 patients with Marfan syn-
drome, 85 underwent aortic root replacement for annuloaortic
ectasia with or without aortic dissection at the initial operation.
These patients were divided into four groups according to the
postoperative condition of the residual aorta (Figure 1).
In group I (n  47), the patients underwent aortic root replace-
ment for annuloaortic ectasia with or without localized dissection
in the ascending aorta. In these patients the remaining aorta in-
cluding the aortic arch was therefore intact. In group II (n  10),
the aortic arch was intact, although the descending thoracic aorta
1374 The Journal of Thoracic and Cardiovascular Surgery ● Mawas dissected because of preoperative Stanford type B dissection.
In the groups III and IV, the patients had Stanford type A dissec-
tion involving the transverse arch associated with annuloaortic
ectasia. In group III (n  13), persistent dissection existed in the
descending thoracic aorta after concomitant total arch replacement.
In group IV (n  15), the residual aortic arch and descending
thoracic aorta were dissected. The distribution of aortic disease in
the groups is shown in Table 1.
This study was approved by the institutional review board of
the National Cardiovascular Center, Osaka, Japan.
Follow-up
Data were prospectively collected from the database of the Na-
tional Cardiovascular Center. Follow-up was performed in all
cases up to May 31, 2002. The mean follow-up time was 110 78
months (maximum 287 months).
Statistical Analysis
The continuous data in this study are expressed as mean value 
SD, and categoric variables are expressed as percentage. Compar-
isons of the characteristics were performed with the 2 test for
nominal variables and the Student t test in the two groups for
continuous and ordinal variables. Actuarial survival and freedom
from reoperation and subsequent arch repair were estimated by the
Kaplan-Meier product-limit method. Survival curves were com-
pared between the groups with the log-rank test. Survivals pre-
sented in this report include in-hospital (death within 30 postop-
Figure 1. Eighty-five patients who underwent aortic root replace-
ment for annuloaortic ectasia at initial operation were divided
into four groups according to postoperative condition of residual
aorta. Group I, all remaining aortas intact (n 47); group II, aortic
arch intact, although type B dissection remained (n  10); group
III, dissection remained in descending thoracic aorta after con-
comitant total arch replacement (n  13); group IV, residual
dissection including aortic arch persisted after aortic root re-
placement alone (n  15).erative days or before hospital discharge). Reoperations that
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ized rates.
Results
Surgical Procedure
Surgical procedures in each group are given in Table 2.
Sixty-eight patients (80.0%) underwent composite graft re-
pair. The prosthetic valves used in this study included 56
mechanical and 12 bioprosthetic valves. Seventeen patients
(20.0%) underwent valve-sparing procedures (13 reimplan-
tation, 4 remodeling).5,10 From 1990 onward, in all the
patients with a dissected arch, excluding 4 who were in a
state of shock, concomitant total arch replacement was
performed. At total arch replacement, cervical vessels were
reconstructed with a branched graft to exclude as much
diseased aortic tissue as possible (Figure 1). This technique
averted the problem of bleeding from the suture line in
dissected aortic tissue.
Operative Morbidity and Mortality
There were 5 early deaths (5.9%). The operative mortalities
were 6.4% (3/47) in group I, 10.0% (1/10) in group II, 0%
in group III, and 6.7% (1/15) in group IV. Causes of death
were low cardiac output (n  1), ventricular tachycardia
(n  1), and sudden cardiac death (n  1) in group I; low
cardiac output (n  1) in group II; and low cardiac output
(n  1) in group IV. Postoperative complications in-
cluded bleeding (n  3), intraoperative balloon pump
insertion (n2), percutaneous extracorporeal membrane
oxygenation support (n  2), stroke (n  1), respiratory
dysfunction (n  3), liver dysfunction (n  4), and renal
failure (n  1) in group I; bleeding (n  1), intraopera-
tive balloon pump insertion (n  1), left ventricular assist
device insertion (n  1), mediastinitis (n  1), and liver
dysfunction (n  1) in group II; bleeding (n  1),
respiratory failure (n  1), intraoperative balloon pump
insertion (n  1), and percutaneous extracorporeal mem-
TABLE 1. Distribution of aortic disease
I (n  47)
Age (y, mean  SD) 38.7 12.7
Male/female ratio 31:16
Sinus of Valsalva (mm, mean  SD) 67.9 13.6
Aortic regurgitation (No.) 39
Type of dissection (No.)
Acute Stanford type A 2*
Chronic Stanford type A 5*
Acute Stanford type B
Chronic Stanford type B
Site of initial tear (No.)
Ascending aorta 7
Descending thoracic aorta
*Localized dissection in ascending aorta.brane oxygenation support (n  1) in group III; and
The Journal of Thoracicbleeding (n  1), renal failure (n  1), and respiratory
failure (n  1) in group IV.
Reoperation
Thirty-seven (46.3%) of 80 patients who survived initial
hospitalization required 67 subsequent operations for the
remaining part of the aorta, valve regurgitation, or late
complications such as pseudoaneurysm formation or pros-
thetic valve dysfunction after the initial operation. Focusing
on reoperations for the residual aorta beyond the location of
earlier repairs, 28 patients required 47 subsequent opera-
tions (Figures 2 and 3). The actuarial freedoms from reop-
eration for all patients were calculated to be 80.3%  4.8%
at 5 years, 59.1%  6.9% at 10 years, and 48.0%  8.1%
at 15 years. The linearized rate of reoperation was 6.0 
11.4 events per 100 patient-years in 80 patients who sur-
vived initial hospitalization.
In group I, 10 of 44 patients who survived initial hospi-
talization underwent the second-stage operation. The actu-
arial freedoms from reoperation in the 44 initial survivors
were 89.5%  5.7% at 5 years, 78.5%  7.4% at 10 years,
II (n  10) III (n  13) IV (n  15)
37.8 7.1 32.4 8.9 34.4 6.9
8:2 7:6 9:6
63.2 7.3 61.5 3.6 64.8 20.2
8 11 12
4 4
9 11
1
9
12 15
10 1
TABLE 2. Types of operations
I
(n  47)
II
(n  10)
III
(n  13)
IV
(n  15)
Bentall 36 7 11 14
Reimplantation 7 3 2 1
Remodeling 4
Concomitant procedure
Coronary artery bypass
grafting
2
Mitral valve plasty 5 1 1
Tricuspid annuloplasty 1
Maze 1
Others 1* 1†
*Ventricular septal defect closure.
†Cesarean delivery and hysterectomy.and 64.3%  11.0% at 15 years. The linearized rate of
and Cardiovascular Surgery ● Volume 127, Number 5 1375
Surgery for Acquired Cardiovascular Disease Tagusari et al
A
CDreoperation was 2.7  5.9 events per 100 patient-years. The
reasons for the second-stage operation were onset of type B
dissection in 7 patients, onset of aortic arch dissection in 2
patients, and abdominal aortic aneurysm in 1 patient. The
time until the onset of type B dissection ranged from 16
months to 14 years after aortic root replacement. The actu-
arial freedoms from operation for the onset of type B
dissection were 89.4%  5.1% at 5 years, 81.2%  7.2% at
10 years, and 73.9%  9.6% at 15 years. In 2 patients who
received total arch replacement, the times after aortic root
replacement until the onset of aortic arch dissection were 5
and 14 years. The actuarial freedoms from aortic arch repair
were 97.0%  3.0% at 5 years, 97.0%  3.0% at 10 years,
89.5%  7.7% at 15 years, and 89.5%  7.7% at 20 years.
In group II, 5 of 9 patients who survived initial hospi-
Figure 2. Outcomes of patients in each group. Numbers in paren-
theses represent in-hospital deaths. TAR, Total arch replacement;
DTAR, descending thoracic aortic replacement; AAR, abdominal
aortic replacement; TAAR, thoracoabdominal aortic replacement;
LD, late death. Asterisk indicates replacement of entire aorta;
dagger indicates femerofemeral bypass for malperfusion because
of acute type B dissection; double dagger indicates external iliac
artery–superior mesenteric artery bypass for malperfusion be-
cause of acute type B dissection.talization required 8 subsequent operations for residual type
1376 The Journal of Thoracic and Cardiovascular Surgery ● MaB dissection. However, there was no onset of arch dissec-
tion or retrograde dissection toward the residual intact aortic
arch. The actuarial freedom from reoperation among the 9
patients who survived initial hospitalization was 55.6% 
16.6% at 5 years. The linearized rate of reoperation was
10.4  10.6 events per 100 patient-years.
In group III, 6 of 13 patients who survived initial hos-
pitalization required 10 subsequent operations for residual
dissection in the descending thoracic aorta. The actuarial
freedoms from reoperation were 47.6%  16.8% at 5 years
and 35.7%  16.3 % at 10 years. The linearized rate of
reoperation was 35.7  16.3 events per 100 patient-years.
In group IV, 7 of 14 patients who survived initial hos-
pitalization required 14 subsequent operations for dissection
in the residual aorta including the aortic arch. The actuarial
freedoms from reoperation were 92.3%  7.4% at 5 years
and 36.9%  16.3% at 10 years. The linearized rate of
reoperation was 10.4  19.5 events per 100 patient-years.
Among the 7 patients who underwent subsequent opera-
tions, 4 underwent total arch replacement. The actuarial
freedoms from subsequent arch repair were 88.9% 10.5%
at 5 years, 64.8% 16.5% at 10 years, and 48.6% 18.7%
at 15 years.
Reoperation in patients with an intact aorta versus
patients with a residual dissecting aorta. As mentioned
previously, the residual aorta was intact after the operation
in group I. On the other hand, patients in groups II, III, and
IV had residual aortic dissection after the operation. Eigh-
teen of 36 patients who survived initial hospitalization with
aortic dissection required 32 subsequent operations. The
actuarial freedoms from reoperation among these patients
Figure 3. Actuarial freedom from reoperation in each group.were 68.8% 8.3% at 5 years, 32.7% 10.6% at 10 years,
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rate of reoperation was 10.2  14.7 events per 100 patient-
years among the 36 patients who survived initial hospital-
ization. There were significant differences in the actuarial
freedom from reoperation (P .0002) and linearized rate of
reoperation (P  .0028) between the patients with and
without aortic dissection.
Reoperation in patients with concomitant total arch
replacement versus patients with aortic root replacement
alone. Between patients with concomitant total arch re-
placement (group III) and patients with aortic root replace-
ment alone (group IV), there were no significant differences
in the actuarial freedom from reoperation (P .177) and the
linearized rate of reoperation (P  .900).
Reoperation for aortic arch in patients with arch dis-
section versus patients without arch dissection. As men-
tioned previously, the residual aortic arch was intact in
groups I and II. Only 2 patients among the 53 group I and
II patients who survived initial hospitalization underwent
subsequent total arch replacement for the onset of aortic
arch dissection. The actuarial freedoms from operation for
the aortic arch were 97.4%  2.5% at 10 years and 90.5%
 7.1% at 20 years (Figure 5). There was a significant
difference (P  .0078) in the actuarial freedom from oper-
ation for the aortic arch between patients with a residual
intact arch (groups I and II) and patients with arch dissec-
tion (group IV).
Late Survival and Late Outcome
There were 14 late deaths (Figure 2). In group I, 7 late
deaths were due to intracerebral bleeding (n  1), septice-
Figure 4. Actuarial freedom from reoperation in patients with and
without residual dissection, showing significant difference in
actuarial freedom from reoperation (P  .0002) between groups.mia (n  1), liver cancer (n  1), renal failure (n  1),
The Journal of Thoracictuberculosis (n 1), and unknown causes (n 2). In group
II, 1 patient died at the second-stage operation of descend-
ing thoracic aorta replacement for type B dissection. In
group III, 2 late deaths occurred as a result of bowel
ischemia subsequent to malperfusion from residual dissec-
tion and an unknown cause. In group IV there were 4 late
deaths. Two patients died of rupture of the residual dissec-
tion. One patient died at the second-stage operation for type
B dissection. One patient died at the fourth-stage operation
for graft replacement of the entire aorta. Overall actuarial
survivals were 85.4%  3.9% at 5 years, 80.0%  4.7% at
10 years, 73.6%  6.2% at 15 years, and 60.6%  10.3%
at 20 years. Actuarial survivals of individual groups are
shown in Figure 6.
Late survival in patients with residual aortic dissection
versus patients without residual aortic dissection. All the
patients in groups II, III, and IV had residual aortic dissec-
tion after the initial operation. Among these patients, the
actuarial survivals were 83.4%  6.3% at 5 years, 79.6% 
7.0% at 10 years, 71.6%  9.9% at 15 years, and 57.3% 
15.0% at 20 years (Figure 7). On the other hand, actuarial
survivals in group I were 86.9%  5.0% at 5 years, 80.2%
 6.5% at 10 years, 74.5%  8.2% at 15 years, and 67.0%
 10.2% at 20 years (Figure 7). There was no significant
difference between group I and the other groups combined
(P  .7657).
Discussion
Aortic root dilatation, with subsequent aortic valve regur-
gitation, aortic dissection, or rupture, is a common and
Figure 5. Actuarial freedom from reoperation for aortic arch in
the patients with and without arch dissection, showing signifi-
cant difference between groups (P  .0078).morbid cardiovascular abnormality in Marfan syndrome.
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ite graft by Bentall and De Bono11 in 1968 significantly
improved the surgical results in such cases. In recent years,
elective surgery has been performed with an operative risk
below 5% to provide a full recovery and a normal life-
style.5-7,12 In our series of operations on patients with
Marfan syndrome, the mortality among patients with aortic
root replacement between 1990 and 2002 was 4.2% (2/48),
which was almost half (8.1%) that in earlier experiences
between 1977 and 1989. Moreover, the life expectancy of
Figure 6. Actuarial survival in each group.
Figure 7. Actuarial survival in patients with and without residual
dissection, showing no significant difference (P .7657) between
groups.patients with Marfan syndrome has significantly improved
1378 The Journal of Thoracic and Cardiovascular Surgery ● Ma(actuarial survivals were 80% at 10 years and 61% at 20
years).
However, the abnormal aortic tissue in Marfan syndrome
requires multiple surgical reconstructions, and the quality of
life of patients with Marfan syndrome is significantly re-
stricted by repeated operations. Of all 85 patients in this
study, 28 (32.9%) required a total number of 47 subsequent
staged operations. This was more common among patients
with residual aortic dissection after the initial operation. In
this study, the actuarial freedom from reoperation among
patients with residual dissection (group II, III, IV) was
significantly lower than that among patients without resid-
ual dissection (group I). The linearized rate of reoperation
was also significantly higher. Unfortunately, this trend of
reoperation was immutable even in patients who received
concomitant total arch replacement for associated type A
dissection. Among patients with aortic dissection in the
aortic arch, there was no significant difference in the actu-
arial freedom from reoperation (P  .177) and the linear-
ized rate of reoperation (P  .900) between patients with
concomitant total arch replacement (group III) and patients
with aortic root replacement alone (group IV). Indeed, more
than 60% of patients with Marfan syndrome require a re-
operation within 10 years, irrespective of whether the total
aortic arch is replaced or not. These results showed that
concomitant total arch replacement was therapeutic but not
curative, because multiple reentries in the fragile dissected
septum in Marfan syndrome disturbed the thrombosed clo-
sure of the residual false channel.13-15 On the basis of these
results, controversy still continues regarding whether con-
comitant total arch replacement is necessary for a dissecting
aortic arch.16,17 Concerning the second-stage operation,
however, it is generally accepted that replacement of the
descending thoracic aorta through left thoracotomy is pref-
erable to total arch replacement through median resternot-
omy. Additionally, regarding the staged operation for entire
aorta replacement, concomitant total arch replacement is
more advantageous than aortic root replacement alone.
Among our patients, 4 patients in group III had a complete
aortic reconstruction with a total of 12 operations, whereas
3 patients in group IV had complete aortic reconstruction
with a total of 12 operations (Figure 2). We therefore
recommend total arch replacement for type A dissection
involving the aortic arch simultaneously with aortic root
replacement for annuloaortic ectasia as long as the patient’s
condition permits this.
Another point highlighted by this study is the late fate of
the residual intact arch after aortic root replacement with
abnormal tissue, that is, the potential risk of dissection or
rupture in the future. This is a key to answering the primary
question of whether the intact aortic arch should be replaced
prophylactically and aggressively at the time of aortic root
replacement for annuloaortic ectasia.
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injury and repair of the aortic media by the turbulence of
blood flow.18 The initial intimal tear of a dissection is most
frequently situated within the first few centimeters of the
ascending aorta.19 In Marfan syndrome, aortic dissection
sometimes occurs in a normal-sized ascending aorta, al-
though the aortic root and sinus of Valsalva are enlarged.8
On the basis of our results, we propose the possible mech-
anism of a tear in ascending aorta among patients with
Marfan syndrome as follows. Turbulence in the ascending
aorta is exacerbated by both the velocity of ejected blood
and the interface between the ejected blood and the rela-
tively stagnant blood. However, in a normal aortic root, the
position of the leaflets helps to reduce turbulence by mask-
ing the dilated sinuses and producing a uniform diameter
above the ventriculoarterial junction when blood is ejected
through the valve orifice.20-24 In contrast, in a gourdlike
aortic root, which is typical of annuloaortic ectasia in
Marfan syndrome, this mechanism is not effective. The
high-velocity flow of ejected blood reaches the ascending
aortic wall with medial degeneration, and turbulence occurs
at the junction between the ascending aorta and the dilated
sinus of Valsalva because the leaflets cannot mask the
dilated sinus of Valsalva (Figure 8).25 Another factor in
dissection is the different tensile strength of the aortic wall
itself, which depends on the content of elastic fibers and
collagen. The contents of elastic fibers and collagen differ
between the ascending aorta and the sinus of Valsalva26-30
and also between the inner and outer layers of the aortic
wall itself. This leads to the “breaking point” of the internal
layer in the ascending aorta during aortic dilatation.21
Therefore these two major factors will be eliminated by
composite graft replacement of the dilated sinus of Valsalva
and the proximal ascending aorta. This hypothesis is sup-
ported by the long-term results of patients with an intact
arch in our study. The incidence of new dissection in the
residual intact arch after aortic root replacement was ex-
tremely low; only 2 of the 53 patients who survived initial
hospitalization with an intact arch underwent subsequent
total arch replacement for the onset of arch dissection,
whereas 4 of the 14 patients who survived initial hospital-
ization with dissection in the aortic arch underwent subse-
quent total arch replacement. These results show that pro-
phylactic replacement of the intact aortic arch is not
necessary at the time of aortic root replacement for annu-
loaortic ectasia, because aortic root replacement itself plays
a prophylactic role in aortic dissection.
The major limitation of our study was that the time scale
of this study ranged through 22 years. During this period
mortality and morbidity in aortic surgery were clearly im-
proved by refinements in surgical technique and periopera-
tive management. Additionally, a large proportion of the
patients required ongoing treatment and follow-up. Another
The Journal of Thoraciclimitation of this study was that the numbers of patients in
each group were too small to ascertain any statistically
significant difference between groups for operative mortal-
ity or the necessity for reintervention.
In conclusion, the incidence of new dissection in the
residual intact arch after aortic root replacement is ex-
tremely low, because aortic root replacement may remove
the factors provoking dissection. According to our results,
prophylactic replacement of the intact arch in Marfan syn-
drome is not necessary during aortic root replacement for
annuloaortic ectasia.
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Discussion
Dr Nicholas Kouchoukos (St Louis, Mo). In their study, Tagusari
and colleagues have focused on the question of whether the aortic
1380 The Journal of Thoracic and Cardiovascular Surgery ● Maarch should be replaced at the time of replacement of the dilated
aortic root in patients with Marfan syndrome. Among the 57
patients with an intact arch at the time of aortic root replacement,
only 2 required subsequent arch replacement for new-onset arch
dissection. The actuarial freedom of reoperation in this group was
90% at 10 years. These observations are in agreement with the
results of other large series of patients with Marfan syndrome and
an intact arch who have undergone only aortic root replacement.
The aggregate experience strongly suggests that replacement of the
arch is not indicated in this setting.
What is less clear is whether the aortic arch should be replaced
at the time of aortic root replacement in patients with acute or
chronic type A dissection. Albeit the number of patients with
dissection in this series was small, 29 patients, no difference in
survival or in freedom from any operation was observed at 10
years between the 15 patients undergoing only aortic root replace-
ment and the 13 patients who had aortic root and simultaneous
arch replacement. However, the rate of reoperation on the aortic
arch was significantly higher among the patients with dissected
arch who underwent only aortic root replacement than among the
patients with an intact arch. This suggests that replacement of the
dissected arch may be advantageous.
Only 10 of the 46 patients with dissection in this series had
acute dissection. Tagusari and colleagues did not examine out-
comes in this subgroup, presumably because of small numbers.
However, the decision to replace the aortic arch in the presence of
acute dissection may be associated with higher risk than if the
dissection is chronic.
I have several questions for Dr Tagusari. First, on the basis of
your findings, what is your current strategy for management of
patients undergoing aortic root replacement who have a type A
dissection?
Dr Tagusari. We perform aortic root replacement with com-
posite graft and total arch replacement.
Dr Kouchoukos. Do you manage the patients with acute dis-
section in this setting any differently than you manage the patients
with chronic dissection?
Dr Tagusari. In general, the patient with Marfan syndrome
who has an aortic dissection is young. Accordingly, we should
perform total arch replacement simultaneously to save further
operation.
Dr Kouchoukos. Do you recommend complete aortic arch
replacement in the setting of acute dissection?
Dr Tagusari. Yes.
Dr Kouchoukos. A valve-sparing procedure was performed in
17 of the 86 patients in the series. How much of the ascending
aorta was replaced in these patients? Do you believe, from your
experience to date, that this is a durable procedure in patients with
Marfan syndrome?
Dr Tagusari. For the patient with Marfan syndrome, I prefer a
composite graft replacement to valve-sparing operation, especially
a remodeling procedure, because in our histologic findings the
aortic valve showed concentric layering of collagen fibers mixed
with glycosaminoglycans. This means severe degeneration of the
leaflet itself. Actually, 4 of the 17 patients who underwent valve-
sparing operations (2 of 13 reimplantations and 2 of 4 remodel-
ings) needed aortic valve replacement.
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